CHRU Jean Minjoz

Besançon 11 trials 4 recruiting

11 Registered trials

4 Currently recruiting

Organisation

CHRU Jean Minjoz

Location

Besançon, France

Identifier

ORL-000005653

Address

3 Boulevard Alexandre Fleming, 25030, France

Departments

Hémato-Onco-Pédiatrie
Hématologie
Hépato-Gastroentérologie
Infectious Diseases
Medical Oncology
ONCOLOGIE
oncology
Pneumology

Clinical trials at this site (11)

Search interface

Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NIPISAFE) Pending

2024-518138-10-00 Patients with DMMR and/or MSI metastatic colorectal can 4
A phase 1, open-label, dose-escalation and dose-expansion study evaluating the safety, feasability and efficacy of ODI-2001 vaccine, a perso… Pending

2025-523172-23-00 Metastatic or locally advanced pancreatic cancer 1
WIthdrawal of DUpilumab in Severe Asthma : a randomised non-inferiority-controlled trial Recruiting

2024-516789-13-00 Severe asthma 6 2025-12-15
Efficacy and safety of bezafibrate 400 mg and bezafibrate 200 mg as adjunctive treatments in patients with primary biliary cholangitis and n… Recruiting

2023-504086-23-00 Subjects with PBC with a non-optimal response to UDCA. 5 2025-03-27
Treatment of microstellite stable metastatic colorectal cancer presenting high immune infiltrate with chemotherapy (XELOX or FOLFOX Bevacizu… Recruiting

2024-515788-73-00 MICROSATELLITE STABLE (MSS) METASTATIC COLORECTAL CANCE 4 2024-07-30
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Staphylococcus aureus bacteremia 6 2023-10-26
Loc-R01: Randomized Phase IB/II Study of escalating doses of Lenalidomide and Ibrutinib in association with R-MPV as a targeted induction tr… Ended

2024-515331-30-00 Primary Central Nervous System Lymphoma (PCNSL) 7 2020-10-30
Randomized phase 2 trial of two chemotherapy regimens plus or minus bevacizumab in patients with well differentiated pancreatic neuroendocri… Ended

2023-505286-84-00 Pancreatic well differentiated neuroendocrine tumors (N 4 2018-06-25
Treatment protocol for osteosarcomas in children, adolescents and adults including a randomized trial and biological studies Ended

2024-514756-32-00 High grade osteosarcoma 5 2007-03-19
Prospective and multicentre evaluation of 3 different doses of IV busulfan associated with fludarabine and thymoglobuline in the conditionin… Ended

2024-516435-27-00 High-risk myeloïd malignancies 4 2024-11-05
Study to compare overall survival (OS) between subjects who receive SBP-101 and those who do not receive SBP-101 (i.e., placebo) in combinat… Ended

2024-514714-12-00 Metastatic Pancreatic Ductal Adenocarcinoma 10 2022-11-11